441 related articles for article (PubMed ID: 31780392)
1. The Predictive Value of Pre-/Postneoadjuvant Chemoradiotherapy MRI Characteristics for Patient Outcomes in Locally Advanced Rectal Cancer.
Meng Y; Wan L; Zhang C; Wang C; Ye F; Li S; Zou S; Cheng J; Xu K; Zhou C; Zhang H
Acad Radiol; 2020 Sep; 27(9):e233-e243. PubMed ID: 31780392
[TBL] [Abstract][Full Text] [Related]
2. MRI morphologic and clinicopathologic characteristics for predicting outcomes in patients with locally advanced rectal cancer.
Meng Y; Wan L; Ye F; Zhang C; Zou S; Zhao X; Xu K; Zhang H; Zhou C
Abdom Radiol (NY); 2019 Nov; 44(11):3652-3663. PubMed ID: 30456561
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment MRI-detected extramural venous invasion as a prognostic and predictive biomarker for neoadjuvant chemoradiotherapy in non-metastatic rectal cancer: a propensity score matched analysis.
Yang SY; Bae H; Seo N; Han K; Han YD; Cho MS; Hur H; Min BS; Kim NK; Lee KY; Lim JS
Eur Radiol; 2024 Jun; 34(6):3686-3698. PubMed ID: 37994967
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes of different neoadjuvant treatment regimens in patients with locally advanced rectal cancer and MRI-detected extramural venous invasion.
Chen M; Ma Y; Song YW; Huang J; Gao YH; Zheng J; He F
Cancer Med; 2023 Nov; 12(21):20523-20537. PubMed ID: 37864414
[TBL] [Abstract][Full Text] [Related]
5. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
[No Abstract] [Full Text] [Related]
6. Magnetic resonance imaging performed before and after preoperative chemoradiotherapy in rectal cancer: predictive factors of recurrence and prognostic significance of MR-detected extramural venous invasion.
Prampolini F; Taschini S; Pecchi A; Sani F; Spallanzani A; Gelsomino F; Kaleci S; Torricelli P
Abdom Radiol (NY); 2020 Oct; 45(10):2941-2949. PubMed ID: 30483843
[TBL] [Abstract][Full Text] [Related]
7. Prognostic risk factors and survival models for T3 locally advanced rectal cancer: what can we learn from the baseline MRI?
Zhao Q; Wan L; Zou S; Zhang C; E T; Yang Y; Ye F; Zhao X; Ouyang H; Zhang H
Eur Radiol; 2021 Jul; 31(7):4739-4750. PubMed ID: 34003351
[TBL] [Abstract][Full Text] [Related]
8. Developing a prediction model based on MRI for pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Wan L; Zhang C; Zhao Q; Meng Y; Zou S; Yang Y; Liu Y; Jiang J; Ye F; Ouyang H; Zhao X; Zhang H
Abdom Radiol (NY); 2019 Sep; 44(9):2978-2987. PubMed ID: 31327039
[TBL] [Abstract][Full Text] [Related]
9. MRI-detected tumor deposits in cT3 and cT4 rectal cancer following neoadjuvant chemoradiotherapy.
Que YT; Chen Y; Yang XY; Ma YR; Liu YY; Wen ZQ; Lu BL; Wu XH; Zhang ZW; Wu YZ; Yu SP; Yuan JP
Eur Radiol; 2024 May; 34(5):2963-2973. PubMed ID: 37840101
[TBL] [Abstract][Full Text] [Related]
10. Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study.
Wang Y; Yang L; Bao H; Fan X; Xia F; Wan J; Shen L; Guan Y; Bao H; Wu X; Xu Y; Shao Y; Sun Y; Tong T; Li X; Xu Y; Cai S; Zhu J; Zhang Z
PLoS Med; 2021 Aug; 18(8):e1003741. PubMed ID: 34464382
[TBL] [Abstract][Full Text] [Related]
11. PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer.
Sclafani F; Brown G; Cunningham D; Wotherspoon A; Tait D; Peckitt C; Evans J; Yu S; Sena Teixeira Mendes L; Tabernero J; Glimelius B; Cervantes A; Thomas J; Begum R; Oates J; Chau I
Ann Oncol; 2016 Aug; 27(8):1557-65. PubMed ID: 27217542
[TBL] [Abstract][Full Text] [Related]
12. Low- Versus High-Risk Rectal Cancer Based on MRI Features: Outcomes in Patients Treated Without Neoadjuvant Chemoradiotherapy.
Jia XX; Wang Y; Cheng J; Yao X; Yin MJ; Zhou J; Ye YJ
AJR Am J Roentgenol; 2018 Aug; 211(2):327-334. PubMed ID: 29927331
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Tumor Regression Grade on MR in Rectal Cancer: A Large-Scale, Single-Center Experience.
Yoen H; Park HE; Kim SH; Yoon JH; Hur BY; Bae JS; Kim JH; Oh HJ; Han JK
Korean J Radiol; 2020 Sep; 21(9):1065-1076. PubMed ID: 32691542
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long-term survival in locally advanced rectal cancer treated by chemoradiotherapy.
Jalil O; Afaq A; Ganeshan B; Patel UB; Boone D; Endozo R; Groves A; Sizer B; Arulampalam T
Colorectal Dis; 2017 Apr; 19(4):349-362. PubMed ID: 27538267
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
16. MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Wan L; Peng W; Zou S; Ye F; Geng Y; Ouyang H; Zhao X; Zhang H
Acad Radiol; 2021 Nov; 28 Suppl 1():S95-S104. PubMed ID: 33189550
[TBL] [Abstract][Full Text] [Related]
17. [Prognosis and complications of local excision for rectal cancer after neoadjuvant chemoradiotherapy].
Li YH; Qiu XY; Lin GL; Zhou JL; Xiao Y; Qiu HZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):344-351. PubMed ID: 33878824
[No Abstract] [Full Text] [Related]
18. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
Dudani S; Marginean H; Tang PA; Monzon JG; Raissouni S; Asmis TR; Goodwin RA; Gotfrit J; Cheung WY; Vickers MM
BMC Cancer; 2019 Jul; 19(1):664. PubMed ID: 31277604
[TBL] [Abstract][Full Text] [Related]
19. MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial.
Patel UB; Brown G; Machado I; Santos-Cores J; Pericay C; Ballesteros E; Salud A; Isabel-Gil M; Montagut C; Maurel J; Ramón-Ayuso J; Martin N; Estevan R; Fernandez-Martos C
Ann Oncol; 2017 Feb; 28(2):344-353. PubMed ID: 28426108
[TBL] [Abstract][Full Text] [Related]
20. Changes in serum uric acid, serum uric acid/serum creatinine ratio, and gamma-glutamyltransferase might predict the efficacy of neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Shao Z; Xu Y; Zhang X; Zou C; Xie R
Strahlenther Onkol; 2024 Jun; 200(6):523-534. PubMed ID: 37286741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
